Microplate Blowdown Evaporator for LC/MS Porvair
The Ultravap Levante is a new introduction to Porvair Sciences’ popular series of nitrogen blowdown sample concentrators and evaporators.
With the needs of LC/MS users very much in mind, the Ultravap Levante offers rapid programmable dry down of samples dissolved in common chromatography solvents such as acetonitrile, dichloromethane and methanol. With 10 stored programs and a full colour screen the Ultravap Levante is both easy to use and highly productive. The plate stage can be programmed to rise as evaporation proceeds, ensuring faster dry down. Both gas temperature and flow rate can be programmed for each stage of a dry-down method and stored in instrument memory. RS232 connection allows the Ultravap Levante to be controlled from a computer or liquid handling robot in addition to the integral touchscreen. A choice of spiral or straight blow-down needles enables the fastest results to be achieved with every type of microplate.
Porvair have re-designed the classic single plate blowdown evaporator to meet the needs of the modern laboratory. The Ultravap Levante now makes it even easier to integrate an automatic dry down step into your biological sample preparation protocol.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.